Standard BioTools (LAB) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Standard BioTools Revenue Highlights

Latest Revenue (Y)

$85.33M

Latest Revenue (Q)

$19.55M

Main Segment (Y)

Product

Main Geography (Y)

EMEA

Standard BioTools Revenue by Period

Standard BioTools Revenue by Year

Date	Revenue	Change
2025-12-31	$85.33M	-51.08%
2024-12-31	$174.43M	64.03%
2023-12-31	$106.34M	8.57%
2022-12-31	$97.95M	-24.99%
2021-12-31	$130.58M	-5.47%
2020-12-31	$138.14M	17.83%
2019-12-31	$117.24M	3.79%
2018-12-31	$112.96M	10.82%
2017-12-31	$101.94M	-2.40%
2016-12-31	$104.45M	-8.95%
2015-12-31	$114.71M	-1.50%
2014-12-31	$116.46M	63.60%
2013-12-31	$71.18M	36.02%
2012-12-31	$52.33M	22.09%
2011-12-31	$42.87M	27.73%
2010-12-31	$33.56M	32.06%
2009-12-31	$25.41M	65.58%
2008-12-31	$15.35M	110.96%
2007-12-31	$7.28M	13.71%
2006-12-31	$6.40M	-95.10%
2001-12-31	$130.58M	-

Standard BioTools generated $85.33M in revenue during NA 2025, up -51.08% compared to the previous quarter, and up 61.77% compared to the same period a year ago.

Standard BioTools Revenue by Quarter

Date	Revenue	Change
2025-09-30	$19.55M	-10.16%
2025-06-30	$21.76M	-46.66%
2025-03-31	$40.80M	-12.68%
2024-12-31	$46.72M	3.89%
2024-09-30	$44.97M	20.87%
2024-06-30	$37.20M	-18.30%
2024-03-31	$45.54M	61.56%
2023-12-31	$28.19M	11.12%
2023-09-30	$25.37M	-8.31%
2023-06-30	$27.67M	10.14%
2023-03-31	$25.12M	-7.04%
2022-12-31	$27.02M	5.36%
2022-09-30	$25.65M	36.58%
2022-06-30	$18.78M	-29.15%
2022-03-31	$26.50M	-30.74%
2021-12-31	$38.27M	34.24%
2021-09-30	$28.50M	-8.10%
2021-06-30	$31.02M	-5.42%
2021-03-31	$32.79M	-26.48%
2020-12-31	$44.61M	11.91%
2020-09-30	$39.86M	52.97%
2020-06-30	$26.06M	-5.65%
2020-03-31	$27.62M	-14.87%
2019-12-31	$32.44M	22.43%
2019-09-30	$26.50M	-6.03%
2019-06-30	$28.20M	-6.36%
2019-03-31	$30.11M	-6.85%
2018-12-31	$32.33M	11.61%
2018-09-30	$28.96M	9.59%
2018-06-30	$26.43M	4.67%
2018-03-31	$25.25M	-9.00%
2017-12-31	$27.75M	12.11%
2017-09-30	$24.75M	3.49%
2017-06-30	$23.91M	-6.35%
2017-03-31	$25.53M	1.79%
2016-12-31	$25.08M	13.04%
2016-09-30	$22.19M	-21.22%
2016-06-30	$28.17M	-2.88%
2016-03-31	$29.00M	-5.60%
2015-12-31	$30.72M	7.26%
2015-09-30	$28.64M	0.09%
2015-06-30	$28.62M	7.07%
2015-03-31	$26.73M	-20.19%
2014-12-31	$33.49M	13.01%
2014-09-30	$29.64M	7.35%
2014-06-30	$27.61M	7.32%
2014-03-31	$25.72M	23.19%
2013-12-31	$20.88M	14.18%
2013-09-30	$18.29M	4.62%
2013-06-30	$17.48M	20.26%
2013-03-31	$14.54M	-7.18%
2012-12-31	$15.66M	22.51%
2012-09-30	$12.78M	-1.28%
2012-06-30	$12.95M	18.30%
2012-03-31	$10.95M	-15.78%
2011-12-31	$13.00M	22.65%
2011-09-30	$10.60M	0.19%
2011-06-30	$10.58M	21.61%
2011-03-31	$8.70M	-16.01%
2010-12-31	$10.36M	22.31%
2010-09-30	$8.47M	5.52%
2010-06-30	$8.02M	19.46%
2010-03-31	$6.72M	-11.90%
2009-12-31	$7.62M	-

Standard BioTools generated $19.55M in revenue during Q3 2025, up -10.16% compared to the previous quarter, and up 52.55% compared to the same period a year ago.

Standard BioTools Revenue Breakdown

Standard BioTools Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Service and Other Revenue	$23.67M	-	-	-	-
Consumables	$36.25M	$60.06M	$41.74M	$46.79M	$57.88M
Instruments	$25.41M	$28.50M	$37.46M	$25.66M	$42.50M
Product	$61.66M	$88.57M	$79.20M	$72.45M	$100.38M
Product And Service	-	$169.70M	$105.18M	$96.17M	-
Collaboration and Other Revenue	-	$4.73M	-	-	-
Service	-	$81.13M	$25.98M	$23.71M	$25.92M
Product and Service, Other	-	-	$1.16M	$964.00K	$1.73M
License	-	-	-	$964.00K	$147.00K
Grant	-	-	-	-	$1.58M
Collaboration Revenue	-	-	-	$818.00K	$2.56M

Standard BioTools's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (41.95%), Consumables (24.66%), Instruments (17.29%), and Service and Other Revenue (16.10%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20
Instruments	$4.47M	$7.32M	$5.09M	$5.21M	$7.78M	$18.02M	$5.59M	$4.90M	$16.87M	$9.00M	$11.59M	$2.66M	$7.52M	$14.55M	$10.06M	$10.18M	$7.71M	-	-	-
Product	$15.45M	$9.95M	$13.80M	$15.67M	$22.23M	$45.38M	$19.59M	$23.59M	$38.82M	$18.71M	$21.66M	$20.92M	$19.31M	$12.22M	$20.00M	$31.08M	$21.94M	$22.63M	$24.73M	$34.35M
Service and Other Revenue	$5.69M	$11.83M	$5.75M	$6.09M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Consumables	$10.98M	$2.63M	$8.71M	$10.46M	$14.45M	$35.65M	$14.01M	$10.41M	$21.95M	$9.71M	$10.08M	$9.56M	$12.48M	$16.53M	$11.88M	$12.45M	$17.02M	-	-	-
Collaboration and Other Revenue	-	-	-	-	$956.00K	$2.87M	$938.00K	$921.00K	-	-	-	-	-	-	-	-	-	-	-	-
Product And Service	-	-	-	-	$39.84M	$81.05M	$44.03M	$44.62M	$52.41M	$25.28M	$27.49M	$26.82M	-	-	-	-	-	-	-	-
Service	-	-	-	-	$17.61M	$35.67M	$24.44M	$21.03M	$13.59M	$6.57M	$5.82M	$5.91M	$5.86M	$5.81M	$6.14M	$6.99M	$6.02M	$6.63M	$6.29M	$6.12M
Product and Service, Other	-	-	-	-	-	-	-	-	$892.00K	$90.00K	$180.00K	$-621.00K	$396.00K	$268.00K	$54.00K	$461.00K	$914.00K	$300.00K	$1.45M	-
Grant	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$461.00K	$821.00K	$300.00K	-
License	-	-	-	-	-	-	-	-	-	-	-	-	-	$396.00K	$268.00K	$54.00K	-	$93.00K	-	-
Collaboration Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$356.00K	$88.00K	$139.00K	$90.00K	$1.48M	$2.69M	-

Standard BioTools's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Product (42.22%), Consumables (30.01%), Service and Other Revenue (15.55%), and Instruments (12.21%).

Standard BioTools Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
EMEA	$35.99M	$52.32M	$36.20M	$33.14M	$42.72M
Asia Pacific	$18.78M	$28.65M	$23.94M	$20.83M	$23.98M
Americas	$30.56M	$93.46M	$46.20M	$43.98M	$63.88M

Standard BioTools's latest annual revenue breakdown by geography, as of Dec 25: EMEA (42.17%), Americas (35.81%), and Asia Pacific (22.01%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
EMEA	$9.36M	$7.01M	$7.25M	$9.13M	$12.61M	$23.75M	$16.06M	$12.52M	$8.77M	$8.16M	$11.44M	$7.84M	$10.78M	$8.07M	$5.67M	$8.61M	$14.25M	$10.11M	$9.22M	$9.14M
Americas	$7.75M	-	$7.84M	$8.69M	$18.97M	$45.05M	$23.75M	$24.66M	$13.22M	$10.87M	$10.45M	$11.66M	$10.50M	$11.12M	$9.43M	$12.93M	$16.22M	$13.01M	$16.12M	$18.52M
Asia Pacific	$4.04M	$1.16M	$4.46M	$3.94M	$9.21M	$15.13M	$5.16M	$8.36M	$6.20M	$6.34M	$5.78M	$5.62M	$5.74M	$6.45M	$3.67M	$4.96M	$7.79M	$5.38M	$5.68M	$5.13M

Standard BioTools's latest quarterly revenue breakdown by geography, as of Mar 26: EMEA (44.27%), Americas (36.64%), and Asia Pacific (19.09%).

Standard BioTools Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SY	So-Young	$1.50B	$318.28M
VREX	Varex Imaging	$844.60M	$216.00M
AVNS	Avanos Medical	$701.20M	$182.20M
BVS	Bioventus	$568.09M	$138.65M
KIDS	OrthoPediatrics	$236.35M	$59.36M
TMCI	Treace Medical Concepts	$212.69M	$47.20M
CTKB	Cytek Biosciences	$201.49M	$44.13M
CBLL	CeriBell	$89.06M	$26.49M
LAB	Standard BioTools	$85.33M	$19.55M
ADCT	ADC Therapeutics	$73.55M	$20.85M
CGEM	Cullinan Therapeutics	-	-

LAB Revenue FAQ

What is Standard BioTools’s yearly revenue?

Standard BioTools's yearly revenue for 2025 was $85.33M, representing a decrease of -51.08% compared to 2024. The company's yearly revenue for 2024 was $174.43M, representing an increase of 64.03% compared to 2023. LAB's yearly revenue for 2023 was $106.34M, representing an increase of 8.57% compared to 2022.

What is Standard BioTools’s quarterly revenue?

Standard BioTools's quarterly revenue for Q3 2025 was $19.55M, a -10.16% decrease from the previous quarter (Q2 2025), and a -56.52% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $21.76M, a -46.66% decrease from the previous quarter (Q1 2025), and a -41.51% decrease year-over-year (Q2 2024). LAB's quarterly revenue for Q1 2025 was $40.8M, a -12.68% decrease from the previous quarter (Q4 2024), and a -10.42% decrease year-over-year (Q1 2024).

What is Standard BioTools’s revenue growth rate?

Standard BioTools's revenue growth rate for the last 3 years (2023-2025) was -19.76%, and for the last 5 years (2021-2025) was -34.65%.

What are Standard BioTools’s revenue streams?

Standard BioTools's revenue streams in c 25 are Service and Other Revenue, Consumables, Instruments, and Product. Service and Other Revenue generated $23.67M in revenue, accounting 16.10% of the company's total revenue Consumables generated $36.25M in revenue, accounting 24.66% of the company's total revenue, down -39.65% year-over-year. Instruments generated $25.41M in revenue, accounting 17.29% of the company's total revenue, down -10.85% year-over-year. Product generated $61.66M in revenue, accounting 41.95% of the company's total revenue, down -30.38% year-over-year.

What is Standard BioTools’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Standard BioTools was Product. This segment made a revenue of $61.66M, representing 41.95% of the company's total revenue.